We provide you with 20 years of free, institutional-grade data for MRNA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRNA. Explore the full financial landscape of MRNA stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-01 | 1682852 | MRNA | 10-Q | Url |
| 2025-05-01 | 1682852 | MRNA | 10-Q | Url |
| 2025-02-21 | 1682852 | MRNA | 10-K | Url |
| 2024-11-07 | 1682852 | MRNA | 10-Q | Url |
| 2024-08-01 | 1682852 | MRNA | 10-Q | Url |
| 2024-05-02 | 1682852 | MRNA | 10-Q | Url |
| 2024-02-23 | 1682852 | MRNA | 10-K | Url |
| 2023-11-03 | 1682852 | MRNA | 10-Q | Url |
| 2023-08-03 | 1682852 | MRNA | 10-Q | Url |
| 2023-05-04 | 1682852 | MRNA | 10-Q | Url |
| 2023-02-24 | 1682852 | MRNA | 10-K | Url |
| 2022-11-03 | 1682852 | MRNA | 10-Q | Url |
| 2022-08-03 | 1682852 | MRNA | 10-Q | Url |
| 2022-05-04 | 1682852 | MRNA | 10-Q | Url |
| 2022-02-25 | 1682852 | MRNA | 10-K | Url |
| 2021-11-04 | 1682852 | MRNA | 10-Q | Url |
| 2021-08-05 | 1682852 | MRNA | 10-Q | Url |
| 2021-05-06 | 1682852 | MRNA | 10-Q | Url |
| 2021-02-26 | 1682852 | MRNA | 10-K | Url |
| 2020-10-30 | 1682852 | MRNA | 10-Q | Url |
| 2020-08-06 | 1682852 | MRNA | 10-Q | Url |
| 2020-05-07 | 1682852 | MRNA | 10-Q | Url |
| 2020-02-27 | 1682852 | MRNA | 10-K | Url |
| 2019-11-06 | 1682852 | MRNA | 10-Q | Url |
| 2019-08-08 | 1682852 | MRNA | 10-Q | Url |
| 2019-05-09 | 1682852 | MRNA | 10-Q | Url |
| 2019-03-13 | 1682852 | MRNA | 10-K | Url |
| 2018-11-09 | 1682852 | MRNA | S-1 | Url |
Moderna, Inc(NASDAQ:MRNA) 
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a tot...
Website: http://www.modernatx.com
Founded: 2010
IPO Price: $23 (Dec 07, 2018)
Full Time Employees: 3,900 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MRNA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.